Absorption, Distribution, Excretion, and Pharmacokinetics of <svg     style="vertical-align:-0.26999pt;width:31.35px;" id="M1" height="22.012501" version="1.1" viewBox="0 0 31.35 22.012501" width="31.35"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.016,-0,0,-.016,.062,10.862)"><path id="x1D7CF" d="M441 24v-24h-373v24q75 2 96 20q22 19 22 85v378q0 70 -36 70q-26 0 -65 -16l-20 -8v26l251 109h18v-570q0 -57 19 -75q19 -17 88 -19z" /></g><g transform="matrix(.016,-0,0,-.016,7.908,10.862)"><path id="x1D7D2" d="M476 255v-111h-64v-144h-145v144h-248v113l313 431h80v-433h64zM60 255h208v294z" /></g>

			<g transform="matrix(.022,-0,0,-.022,16.375,21.612)"><path id="x43" d="M614 175l29 -10q-33 -109 -57 -154q-121 -26 -184 -26q-90 0 -160.5 29t-112.5 77t-63.5 105.5t-21.5 119.5q0 157 108 253t277 96q36 0 71.5 -5t69 -13.5t36.5 -8.5q15 -102 20 -150l-29 -8q-20 79 -66.5 114t-128.5 35q-119 0 -187.5 -86t-68.5 -207
q0 -140 73.5 -227.5t188.5 -87.5q73 0 119.5 37.5t86.5 116.5z" /></g>

		
	
</svg>-Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats

<table>Cumulative activity excretion profile in the urine and feces of male Sprague-Dawley rats at different time period after administration of a single oral dose of 10 mg/kg of <sup>14</sup>C-PNDP (<svg height="11.0375" id="M300" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 35.099998 11.0375" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0375)">
<g transform="translate(72,-63.17)">
<text transform="matrix(1,0,0,-1,-71.95,63.4)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">6</tspan>
</text>
</g>
</g>
</svg>, Mean±S.D.).</table>

BioMed Research International

fig6

Figure 6

Figure 6: Absorption, Distribution, Excretion, and Pharmacokinetics of <svg     style="vertical-align:-0.26999pt;width:31.35px;" id="M1" height="22.012501" version="1.1" viewBox="0 0 31.35 22.012501" width="31.35"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.016,-0,0,-.016,.062,10.862)"><path id="x1D7CF" d="M441 24v-24h-373v24q75 2 96 20q22 19 22 85v378q0 70 -36 70q-26 0 -65 -16l-20 -8v26l251 109h18v-570q0 -57 19 -75q19 -17 88 -19z" /></g><g transform="matrix(.016,-0,0,-.016,7.908,10.862)"><path id="x1D7D2" d="M476 255v-111h-64v-144h-145v144h-248v113l313 431h80v-433h64zM60 255h208v294z" /></g>

			<g transform="matrix(.022,-0,0,-.022,16.375,21.612)"><path id="x43" d="M614 175l29 -10q-33 -109 -57 -154q-121 -26 -184 -26q-90 0 -160.5 29t-112.5 77t-63.5 105.5t-21.5 119.5q0 157 108 253t277 96q36 0 71.5 -5t69 -13.5t36.5 -8.5q15 -102 20 -150l-29 -8q-20 79 -66.5 114t-128.5 35q-119 0 -187.5 -86t-68.5 -207
q0 -140 73.5 -227.5t188.5 -87.5q73 0 119.5 37.5t86.5 116.5z" /></g>

		
	
</svg>-Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats 

Figure 6 | Absorption, Distribution, Excretion, and Pharmacokinetics of 
	
		
			

			

		
	
-Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats 

BioMed Research International

Absorption, Distribution, Excretion, and Pharmacokinetics of -Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats

Figure 6